scholarly journals Patients with Spontaneously Ruptured Hepatocellular Carcinoma Benefit from Staged Surgical Resection after Successful Transarterial Embolization

2015 ◽  
Vol 16 (1) ◽  
pp. 315-319 ◽  
Author(s):  
Dong-Zhi Zhang ◽  
Ke Zhang ◽  
Xiao-Peng Wang ◽  
Hui Cai
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Resection ◽  
Transarterial Embolization ◽  
Ruptured Hepatocellular Carcinoma

Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma

2009 ◽  
Vol 16 (4) ◽  
pp. 508-512 ◽  
Author(s):  
Wing-Hong Li ◽  
Edmond Cheung-Yan Cheuk ◽  
Philip Chong-Hei Kowk ◽  
Moon-Tong Cheung
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transarterial Embolization ◽  
Ruptured Hepatocellular Carcinoma

scholarly journals Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma

2017 ◽  
Vol 11 (1) ◽  
pp. 155-161
Author(s):  
Severin Gloor ◽  
Kai Oliver Jensen ◽  
Stefan Breitenstein ◽  
Christoph A. Binkert ◽  
Eliane Angst ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Rare Case ◽  
Transarterial Embolization ◽  
Interdisciplinary Approach ◽  
Emergency Situation ◽  
Bridging Therapy ◽  
Perioperative Morbidity ◽  
Ruptured Hepatocellular Carcinoma ◽  
Viral Infection Status ◽  
Diagnostics And Therapy

Spontaneous ruptures of hepatocellular carcinoma (HCC) are rare. Nevertheless they may lead to difficult decisions in the emergency situation. The acute therapies include conservative treatment, transarterial embolization and surgery. Curative treatment of HCC can be achieved by liver resection solely. The decision-making depends on prognostic patient’s factors, such as hepatic viral infection status, Child-Pugh grade, liver cirrhosis and number of tumors. In this case transarterial embolization was preferable as a bridging therapy prior to further diagnostics and therapy, to lower the perioperative morbidity and mortality. The therapy of these cases needs an interdisciplinary approach to choose the best possible procedure in each case.

Outcomes of Surgical Resection for Ruptured Hepatocellular Carcinoma

2017 ◽  
Vol 17 (1) ◽  
pp. 54-59
Author(s):  
Hae Won Lee ◽  
Chang-Sup Lim ◽  
Hyo-Sin Kim
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Resection ◽  
Ruptured Hepatocellular Carcinoma

scholarly journals Survival after Locoregional Treatments for Hepatocellular Carcinoma: A Cohort Study in Real-World Patients

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Simona Signoriello ◽  
Annalisa Annunziata ◽  
Nicola Lama ◽  
Giuseppe Signoriello ◽  
Paolo Chiodini ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cohort Study ◽  
Surgical Resection ◽  
Randomized Clinical Trials ◽  
Transarterial Embolization ◽  
Relative Effectiveness ◽  
Percutaneous Ethanol Injection ◽  
Locoregional Therapy ◽  
Propensity Score Method ◽  
Ethanol Injection

Evidence of relative effectiveness of local treatments for hepatocellular carcinoma (HCC) is scanty. We investigated, in a retrospective cohort study, whether surgical resection, radiofrequency ablation (RFA), percutaneous ethanol injection (PEI), and transarterial embolization with (TACE) or without (TAE) chemotherapy resulted in different survival in clinical practice. All patients first diagnosed with HCC and treated with any locoregional therapy from 1998 to 2002 in twelve Italian hospitals were eligible. Overall survival (OS) was the unique endpoint. Three main comparisons were planned: RFA versus PEI, surgical resection versus RFA/PEI (combined), TACE/TAE versus RFA/PEI (combined). Propensity score method was used to minimize bias related to non random treatment assignment. Overall 425 subjects were analyzed, with 385 (91%) deaths after a median followup of 7.7 years. OS did not significantly differ between RFA and PEI (HR 1.11, 95% CI 0.79–1.57), between surgery and RFA/PEI (HR 0.95, 95% CI 0.64–1.41) and between TACE/TAE and RFA/PEI (HR 0.88, 95% CI 0.66–1.17). 5-year OS probabilities were 0.14 for RFA, 0.18 for PEI, 0.27 for surgery, and 0.15 for TACE/TAE. No locoregional treatment for HCC was found to be more effective than the comparator. Adequately powered randomized clinical trials are still needed to definitely assess relative effectiveness of locoregional HCC treatment.

FRI-456-MELD score is the only predictor for 30-day mortality in patients with ruptured hepatocellular carcinoma treated by emergent transarterial embolization

2019 ◽  
Vol 70 (1) ◽  
pp. e596
Author(s):  
Ya-Ting Cheng ◽  
Wei Teng ◽  
Rachel Wen-Juei Jeng ◽  
Yi-Chung Hsieh ◽  
Kar-Wai Lui ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transarterial Embolization ◽  
Meld Score ◽  
Ruptured Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document